Results
Of the total of 225 patients included in the study, 155 had BPH and 70
had PCa with pathology confirmation . The mean age of the patients was
66.54+ 8.19 years, and 67.8+ 6.85 years in Group 1 and Group
2, respectively. As seen in Table 1, the mean total PSA levels of the
patients in Group 1 was 6.37+ 3.98 and Group 2 was
8.62+ 4.25. The total PSA, albumin, and lymphocyte differences
between the groups were statistically significant (p=0.0002, p=0.0001,
p= 0.005). The median value of the HALP scores in Group 1 and 2 were
49.43 and 51.2 respectively, and this was not statistically significant
between two groups (p=0.737).
The HALP score had the least Area Under Curve (AUC) value compared to
the others (0.514). Surprisingly, the AUC of Albumin was larger than PSA
for diagnostic efficacy in PCa patients (0.696-0.656) (Figure 1), but
this was not statistically significant (p=0.4580) (Table 2).
When comparing the different parameters with each other with the ROC
analysis; the PSA levels were not statistically significant to
hemoglobin, albumin level, lymphocyte, platelet count, or the HALP
score. However, the albumin levels were statistically significant
compared to the platelet count and HALP score (p=0.0033, p=0.0068),
except PSA and lymphocyte (p=0.4580, p=0.1717) (Table 2).